EP1007648A4 - Anti-obesity proteins - Google Patents

Anti-obesity proteins

Info

Publication number
EP1007648A4
EP1007648A4 EP97954183A EP97954183A EP1007648A4 EP 1007648 A4 EP1007648 A4 EP 1007648A4 EP 97954183 A EP97954183 A EP 97954183A EP 97954183 A EP97954183 A EP 97954183A EP 1007648 A4 EP1007648 A4 EP 1007648A4
Authority
EP
European Patent Office
Prior art keywords
obesity proteins
obesity
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97954183A
Other languages
German (de)
French (fr)
Other versions
EP1007648A1 (en
Inventor
John M Beals
James A Hoffmann
Allen D Kline
Richard W Schevitz
Faming Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP1007648A1 publication Critical patent/EP1007648A1/en
Publication of EP1007648A4 publication Critical patent/EP1007648A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/5759Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP97954183A 1996-12-20 1997-12-19 Anti-obesity proteins Withdrawn EP1007648A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3354196P 1996-12-20 1996-12-20
US33541P 1996-12-20
PCT/US1997/023549 WO1998028414A1 (en) 1996-12-20 1997-12-19 Anti-obesity proteins

Publications (2)

Publication Number Publication Date
EP1007648A1 EP1007648A1 (en) 2000-06-14
EP1007648A4 true EP1007648A4 (en) 2003-01-15

Family

ID=21871008

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97954183A Withdrawn EP1007648A4 (en) 1996-12-20 1997-12-19 Anti-obesity proteins

Country Status (5)

Country Link
EP (1) EP1007648A4 (en)
JP (1) JP2001507228A (en)
AU (1) AU5802898A (en)
CA (1) CA2274799A1 (en)
WO (1) WO1998028414A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927214B1 (en) 1999-01-15 2005-08-09 Novo Nordisk A/S Non-peptide GLP-1 agonists
DE19957904A1 (en) * 1999-12-01 2001-06-07 Merck Patent Gmbh Insect venom allergens with reduced IgE reactivity and process for their preparation
JP2004532618A (en) * 2001-02-06 2004-10-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Modified leptin with reduced immunogenicity

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996027385A1 (en) * 1995-03-03 1996-09-12 Eli Lilly And Company Anti-obesity proteins
WO1996034111A1 (en) * 1995-04-26 1996-10-31 Eli Lilly And Company Process for preparing anti-obesity protein
WO1997018833A1 (en) * 1995-11-22 1997-05-29 Amgen Inc. Methods of increasing lean tissue mass using ob protein compositions
WO1998027993A1 (en) * 1996-12-20 1998-07-02 Eli Lilly And Company Protein crystals, their preparation and use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5827734A (en) * 1995-01-20 1998-10-27 University Of Washington Materials and methods for determining ob protein in a biological sample
CA2211664A1 (en) * 1995-01-31 1996-08-08 Eli Lilly And Company Anti-obesity proteins
AU5539596A (en) * 1995-04-06 1996-10-23 Amylin Pharmaceuticals, Inc. Anti-obesity agents
GB9509164D0 (en) * 1995-05-05 1995-06-28 Smithkline Beecham Plc Novel compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996027385A1 (en) * 1995-03-03 1996-09-12 Eli Lilly And Company Anti-obesity proteins
WO1996034111A1 (en) * 1995-04-26 1996-10-31 Eli Lilly And Company Process for preparing anti-obesity protein
WO1997018833A1 (en) * 1995-11-22 1997-05-29 Amgen Inc. Methods of increasing lean tissue mass using ob protein compositions
WO1998027993A1 (en) * 1996-12-20 1998-07-02 Eli Lilly And Company Protein crystals, their preparation and use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9828414A1 *

Also Published As

Publication number Publication date
AU5802898A (en) 1998-07-17
JP2001507228A (en) 2001-06-05
EP1007648A1 (en) 2000-06-14
WO1998028414A1 (en) 1998-07-02
CA2274799A1 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
EP0810871A4 (en) Anti-obesity proteins
IL116970A0 (en) Anti-obesity proteins
GB9609702D0 (en) Anticoagulant peptides
ZA9710338B (en) Proteins
SG65040A1 (en) Anti-obesity proteins
IL115317A0 (en) Proteins
ZA984322B (en) Sucrose-binding proteins
GB9413316D0 (en) Novel proteins
EP1007648A4 (en) Anti-obesity proteins
EP0915100A4 (en) Novel protein
GB9613705D0 (en) Novel peptides
ZA971900B (en) Modified proteins
HUP9801371A3 (en) Anti-obesity proteins
GB9707599D0 (en) Proteins
GB9607689D0 (en) Proteins
GB9611896D0 (en) Modified proteins
GB9614293D0 (en) Modified proteins
GB9624028D0 (en) Modified proteins
GB9609405D0 (en) Protein
EP0960198A4 (en) Cd44-like protein
GB9608430D0 (en) Peptides
GB9625227D0 (en) Peptides
GB9626362D0 (en) Peptides
SG55039A1 (en) Peptides
GB9612648D0 (en) Peptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990617

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

A4 Supplementary search report drawn up and despatched

Effective date: 20021204

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/16 A, 7C 07K 14/575 B, 7A 61K 38/22 B

18D Application deemed to be withdrawn

Effective date: 20020702